Texas Pharma Co. Settles Opioid Whistleblower Suit For $2.8M
A pharmacy services company has reached a $2.75 million settlement with the federal government to resolve a whistleblower lawsuit alleging that it allowed opioids and other controlled substances to be dispensed...To view the full article, register now.
Already a subscriber? Click here to view full article